Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Trichoscopy helps diagnose frontal fibrosing alopecia in Caucasians, but more research is needed.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

The treatment improved hair growth in three patients with alopecia.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Early diagnosis of Alopecia Frontal Fibrosante is crucial for effective treatment.

Titanium nanoparticles may trigger frontal fibrosing alopecia, so avoid products with them.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Baricitinib helps treat severe hair loss in people over 65.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Baricitinib is effective and safe for treating severe alopecia areata.

Wearing a hijab changes the common bacteria and fungi on the scalp, possibly affecting skin health.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Baricitinib effectively regrows hair in severe alopecia areata cases.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.